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Background: Data on the association between vitamin D and upper digestive tract neoplasms are limited.
Methods: In two case–control studies in Italy, we examined the relation between dietary vitamin D intake and
squamous cell carcinoma of the esophagus (SCCE; 304 cases) and oral/pharyngeal cancer (804 cases). Odds ratios
(ORs) and 95% confidence intervals (CIs) were estimated by multiple logistic regression.
Results: Adjusted ORs for SCCE and oral/pharyngeal cancer were 0.58 (95% CI 0.39–0.86) and 0.76 (95% CI 0.60–
0.94), respectively, for the highest tertile of vitamin D intake. Using a reference group of those in the highest tertile of
vitamin D who were never/former smokers, ORs were 8.7 (95% CI 4.1–18.7) for SCCE and 10.4 (95% CI 6.9–15.5) for
oral/pharyngeal cancer among heavy smokers in the lowest vitamin D tertile; similarly, compared with those in the
highest tertile of vitamin D who drank <3 alcoholic drinks/day, corresponding ORs were 41.9 (95% CI 13.7–128.6) for
SCCE and 8.5 (95% CI 5.7–12.5) for oral/pharyngeal cancer, among heavy alcohol drinkers in the lowest vitamin D
tertile.
Conclusion: We observed inverse associations between dietary vitamin D intake and risk of SCCE and, perhaps,
oral/pharyngeal cancer, which were most pronounced among heavy current smokers and heavy consumers of
alcohol.
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introduction
Since Garland and Garland [1] first suggested that vitamin D
status may explain inverse ecologic associations between colon
cancer mortality and solar UVB radiation exposure, similar
associations have been hypothesized for breast, ovarian, and
prostate cancers. Inverse ecologic correlations have been
reported between regional solar UVB radiation, latitude, and
other indicators of UV radiation in the United States, Europe,
and Asia and mortality rates for numerous types of cancer,
including colon, rectum, breast, ovary, prostate, stomach,
esophagus, pancreas, and non-Hodgkin’s lymphoma [2–5]. In
one calculation, >23 000 premature cancer deaths in the United
States were estimated to occur annually due to low solar UVB
radiation, the majority of which are cancers of digestive system
organs [2]. In a similar ecologic study in Japan, Mizoue [6]
demonstrated an inverse correlation between average annual
solar radiation levels and mortality from digestive system
cancers but not other types of cancer. Despite these ecologic
findings, there has been very little epidemiologic research on
the association between vitamin D and upper digestive tract
neoplasms (oral, pharyngeal, and esophageal cancer).
We previously examined the influence of dietary intake of
numerous micronutrients on the risk of developing squamous
cell carcinoma of the esophagus (SCCE) [7] and oral and
pharyngeal cancers [8], and we reported modest protective
effects of vitamin D intake. In the present analysis, we have
examined the association between vitamin D and esophageal
and oral and pharyngeal cancers according to categories of
cigarette smoking and alcohol consumption, both strong risk
factors for these cancers, to determine whether there may be
stronger evidence of a protective effect.
methods
Detailed descriptions of the methods of the case–control studies have been
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1997 in the provinces of Pordenone and Padua in northeast Italy and the
greater Milan area in north Italy and includes 304 cases (275 men and 29
women) with a median age of 60 years (range 39–77 years). The study of
oral and pharyngeal cancers was conducted from 1992 to 2005 in the
provinces of Pordenone in northeast Italy, Rome and Latina in central Italy,
and the greater Milan area in north Italy and includes 804 patients (658
men and 146 women) with a median age of 58 years (range 22–78 years); of
these, 405 had cancer of the oral cavity and 399 had cancer of the pharynx.
In both studies, cases were patients with incident, histologically confirmed
cancer and with no prior history of cancer. Controls were admitted for
a variety of acute illnesses to major teaching and general hospitals drawing
from the same study base as the cases. Diseases related to tobacco smoking
(e.g. chronic obstructive bronchitis and cardiovascular disease) or alcohol
abuse (e.g. cirrhosis and pancreatitis) were excluded as causes of hospital
admission, but not as comorbidities, in order to avoid overrepresentation
of smokers and heavy drinkers compared with the source population. For
esophageal cancer, a control-to-case ratio of 5 was chosen for women and 2
for men to compensate for the rarity of SCCE among women; controls were
743 patients (593 men and 150 women), frequency matched to esophageal
cancer cases by gender, age quinquennia, and area of residence, with
a median age of 60 years (range 36–77 years) and with no history of cancer.
Twenty-nine percent of controls were admitted for trauma, mostly sprains
and fractures, 36% for other orthopedic disorders, 12% for acute surgical
conditions, 13% for eye diseases, and 9% for other acute conditions. For
oral and pharyngeal cancers, controls were 2080 patients (1302 men and
778 women) with a median age of 58 years (range 19–79 years), admitted
for traumas (25%), other orthopedic disorders (30%), acute surgical
conditions (19%), eye diseases (9%), and other acute conditions (17%).
Overall, <5% of cases and controls contacted refused to participate.
Cases and controls were interviewed in the hospital by trained personnel
using the same standard structured questionnaire designed to collect
information on sociodemographic characteristics, lifetime smoking and
alcohol drinking habits, physical activity, anthropometric measures,
personal medical history, and family history of cancer. Usual diet during
the 2 years before diagnosis, or hospital admission for controls, was assessed
using an interviewer-administered food frequency questionnaire (FFQ)
with high reproducibility and validity [10, 11]. The FFQ included 78 foods,
groups of food, or recipes. The FFQ was divided into seven sections: (i)
bread, cereals, and first courses; (ii) second courses (e.g. meat and other
main dishes); (iii) side dishes (i.e. vegetables); (iv) fruits; (v) sweets,
desserts, and soft drinks; (vi) milk, hot beverages, and sweeteners; and (vii)
alcoholic beverages. To compute energy and nutrient intakes, including
vitamin D intake, an Italian food composition database as well as
information from additional sources were used [8, 12, 13]. Use of vitamin
supplements was uncommon in this population during the study
period [14].
The data were modeled using unconditional multiple logistic regression
to compute odds ratios (ORs) and corresponding 95% confidence intervals
(CIs) [15]. Adjusted models included terms for quinquennia of age, sex,
study center, education, cigarette smoking, alcohol consumption, and
nonalcohol energy intake. Adjustment for energy was carried out using the
residuals model [16]. We also fitted models across strata of age (< or ‡60
years), sex, and calcium intake (< or ‡median value among controls), as
well as cigarette smoking and alcohol consumption. Vitamin D was entered
into the models as tertiles of intake (based on the distribution among
controls) or as a continuous variable (with the increment of intake set as
the standard deviation among controls = 1.14 lg/day for SCCE and 1.21
lg/day for oral and pharyngeal cancers). Trend tests for risk of cancer
according to tertiles of vitamin D intake were based on a likelihood ratio
test between models with and without a linear term for the vitamin D
tertiles.
results
Cases of SCCE and oral and pharyngeal cancers smoked
cigarettes and drank alcohol substantially more heavily than
their corresponding controls. Level of education was lower
among esophageal cancer cases than controls, but was similar
among oral and pharyngeal cancer cases and controls.
Nonalcohol energy intake was lower among male esophageal
cancer cases and among oral and pharyngeal cancer cases
compared with controls, but was higher among female
esophageal cancer cases than their corresponding controls.
Table 1 shows the distribution of esophageal and oral and
pharyngeal cancer cases and controls, as well as multiple logistic
regression-derived ORs and corresponding 95% CIs, according
to tertiles of vitamin D intake and continuous increments of
intake. For both SCCE and oral and pharyngeal cancers, we
observed a significant trend of decreasing ORs with increasing
Table 1. Multiple logistic regression-derived ORsa and corresponding 95% CIs for esophageal and oral and pharyngeal cancers, according to tertiles of
intake of vitamin D (Italy, 1992–1997)
Tertiles of vitamin D intakeb P value (trend) Continuous ORc
1 (low)d 2 3 (high)
Esophageal cancer
Cases : controls 133 : 247 101 : 247 70 : 249
OR (95% CI) 1.0 0.58 (0.40–0.85) 0.58 (0.39–0.86) 0.003 0.84 (0.71–0.99)
Oral and pharyngeal cancers
Cases : controls 344 : 692 245 : 694 215 : 694
OR (95% CI) 1.0 0.82 (0.66–1.02) 0.76 (0.60–0.94) 0.012 0.91 (0.83–1.00)
aAdjusted for age, sex, study center, education, cigarette smoking, alcohol consumption, and total energy intake.
bTertiles based on distribution among controls; the 33rd and 67th percentiles of estimated vitamin D intake were 2.51 and 3.51 lg/day, respectively, for
esophageal cancer and 2.44 and 3.42 lg/day, respectively, for oral and pharyngeal cancers.
cEstimated for an increment of intake equal to one standard deviation among controls (=1.14 lg/day for esophageal cancer and 1.21 lg/day for oral and
pharyngeal cancers).
dReference category.
OR, odds ratio; CI, confidence interval.
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intake of vitamin D (P trend = 0.003 and 0.012, respectively).
Adjusted ORs for esophageal cancer were 0.58 (95% CI 0.40–
0.85) for the second tertile and 0.58 (95% CI 0.39–0.86) for the
highest tertile of vitamin D intake compared with the lowest;
the continuous OR per 1.14 lg increase in vitamin D intake was
0.84 (95% CI 0.71–0.99). For oral and pharyngeal cancers,
corresponding adjusted ORs for the second and third tertile of
vitamin D intake were 0.82 (95% CI 0.66–1.02) and 0.76 (95%
CI 0.60–0.94), respectively, and the OR per 1.21 lg increase in
vitamin D intake was 0.91 (95% CI 0.83–1.00).
The relation with vitamin D was examined separately by
strata of age, calcium intake, and sex (the latter for oral and
pharyngeal cancers only since there were too few female cases of
esophageal cancer for meaningful evaluation) (Table 2). For
esophageal cancer, the inverse association with vitamin D was
stronger and statistically significant among those aged >60
years, while the opposite appeared true for oral and pharyngeal
cancers. There was little evidence of effect modification by
calcium intake for either cancer type, and none of the tests for
heterogeneity of the ORs was statistically significant.
We evaluated the interaction between vitamin D intake and
both cigarette smoking and alcohol consumption (Table 3). For
esophageal cancer, an inverse association with vitamin D was
apparent among all groups except those who drank <3 drinks/
day, while for oral and pharyngeal cancers, the protective effect
of vitamin D was to a large extent confined to heaviest
smokers and drinkers. Using a common reference group of
those in the highest tertile of vitamin D intake who were never
smokers or former smokers who quit >10 years ago, there
was an almost nine-fold increase in esophageal cancer risk
among heavy smokers of ‡20 cigarettes/day who were in the
lowest tertile of vitamin D intake (OR = 8.7; 95% CI 4.1–18.7).
Similarly, using a common reference group of those in the
highest tertile of vitamin D intake who drank <3 alcoholic
drinks/day, an OR of 41.9 (95% CI 13.7–128.6) for esophageal
cancer was observed among heavy drinkers of ‡7 drinks/day
who were in the lowest tertile of vitamin D intake. For oral
and pharyngeal cancers, using the same common reference
groups, the corresponding ORs were 10.4 (95% CI 6.9–15.5)
for heavy smokers in the lowest tertile of vitamin D and 8.5
(95% CI 5.7–12.5) for heavy alcohol drinkers in the lowest
tertile of vitamin D intake.
discussion
Our results suggest that dietary vitamin D intake is associated
with a decreased risk of SCCE and, somewhat less clearly, with
a decreased risk of oral and pharyngeal cancers. In this study
population, those in the highest tertile of vitamin D intake,
corresponding to intake >3.5 lg/day, had risk reductions of
40% for esophageal cancer and 25% for oral and pharyngeal
cancers. The inverse association of both cancers with vitamin D
intake was most pronounced among, or confined to, those
who were heavy current smokers (‡20 cigarettes/day) and
heavy consumers of alcohol (‡7 drinks/day).
A large number of epidemiologic studies have fairly
consistently demonstrated an inverse association between
dietary or supplementary vitamin D intake, as well as serum
25(OH)D levels, and colorectal cancer [17–19]. In those
studies, risk reductions for the highest categories of intake
(generally corresponding to a mean of 17.5–20 lg/day) versus
the lowest ones have ranged between 30% and 50% [17, 18]. As
Table 2. Multiple logistic regression-derived ORsa and corresponding 95% CIs for esophageal and oral and pharyngeal cancers, according to tertiles of
intake of vitamin D across strata of age, calcium intake, and sex (Italy, 1992–1997)




<60 141 : 344 1 0.68 (0.39–1.19) 0.69 (0.38–1.26)
‡60 163 : 399 1 0.55 (0.32–0.93) 0.52 (0.29–0.91)
Calcium (mg/day)
<1036.9 178 : 372 1 0.51 (0.31–0.86) 0.72 (0.41–1.27)
‡1036.9 126 : 371 1 0.67 (0.38–1.19) 0.47 (0.25–0.86)
Oral and pharyngeal cancers
Age (years)
<60 433 : 1132 1 0.91 (0.67–1.22) 0.66 (0.48–0.91)
‡60 371 : 948 1 0.73 (0.53–1.01) 0.90 (0.65–1.25)
Calcium (mg/day)
<884.0 464 : 1040 1 0.84 (0.63–1.11) 0.74 (0.54–1.01)
‡884.0 340 : 1040 1 0.82 (0.59–1.14) 0.76 (0.54–1.07)
Sex
Male 658 : 1301 1 0.68 (0.53–0.88) 0.77 (0.59–1.00)
Female 146 : 779 1 1.55 (0.99–2.43) 0.83 (0.51–1.34)
aAdjusted for age, sex, study center, education, cigarette smoking, alcohol consumption, and total energy intake.
bTertiles based on distribution among controls.
cReference category.
OR, odds ratio; CI, confidence interval.
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expected, the levels of dietary vitamin D intake were
substantially lower in our Italian population; the main dietary
sources of vitamin D in this population were fish (49.4%), meat
(25.8%), eggs (7.2%), and cheese (4.9%), with little food
fortification or use of supplements. It is therefore surprising
that the magnitudes of the risk reductions we observed for
esophageal and oral and pharyngeal cancers were similar to
those observed for colorectal cancer in other populations with
much higher levels of intake. We did not have measurements of
circulating levels of 25(OH)D, which is a biomarker for vitamin
D status [20]. It has been demonstrated that dietary (and
supplemental) vitamin D intake predicts only a relatively small
proportion of the variation in 25(OH)D levels, while skin
pigmentation, outdoor sunlight exposure, geographic region of
residence, season, body mass index, and genetic differences in
vitamin D receptor expression are strong predictors of
25(OH)D levels [21, 22].
Evidence for a protective effect of vitamin D on cancer other
than colorectal cancer, in particular SCCE or oral and
pharyngeal cancers, is substantially more limited. Most dietary
studies of oral and pharyngeal cancers have focused on
nutrients correlated with diets rich in fruits and vegetables,
which have been shown to be inversely associated with these
types of cancer. In a recent meta-analysis of ecologic studies,
reduced risk of esophageal cancer was reported following
a diagnosis of nonmelanoma skin cancer, used as a surrogate
for high cumulative UVB irradiance [23]. A few observational
studies have generally presented relevant results for cancers of
the digestive system combined, due to small numbers of
esophageal cancer cases. Freedman et al. [24] recently
conducted a prospective study of serum 25(OH)D levels and
cancer mortality among 16 818 participants in the Third
National Health and Nutrition Examination Survey (NHANES
III). Those with serum 25(OH)D levels >50 nmol/l had
a significantly lower risk of colorectal cancer mortality
compared with lower levels, but there was no relation between
25(OH)D level and total cancer mortality or cancer at digestive
sites other than the colon.
In the Health Professionals Follow-up Study [25], black men
had substantially higher risk of digestive system (oral cavity,
esophagus, stomach, pancreas, colon, and rectum combined)
cancer incidence and mortality compared with whites. Blacks in
the United States have been shown to have lower levels of
vitamin D compared with whites [24, 26, 27], and this vitamin
D insufficiency has been hypothesized as a possible explanation
for excess cancer incidence and mortality among blacks [28].
Giovannucci et al. [21] also computed a predicted level of
25(OH)D for men in the Health Professionals Follow-up Study,
based on the combined influence of various major
determinants of 25(OH)D, including race, dietary and
supplementary vitamin D, body mass index, and geographic
region of residence. An increment of 25 nmol/l in the predicted
25(OH)D level (which approximates the difference between the
highest and lowest decile in that population) was inversely
associated with total cancer incidence and mortality as well as
risk for the major digestive organ cancers, including esophageal
cancer (relative risk (RR) = 0.37; 95% CI 0.17–0.80) and oral
and pharyngeal cancers (RR = 0.30; 95% CI 0.11–0.81).
In a prospective study in Linxian, China, in a population
with very high rates of SCCE and low dietary intake of vitamin
Table 3. Multiple logistic regression-derived ORsa and corresponding 95% CIs for esophageal and oral and pharyngeal cancers, according to intake of
vitamin D across strata of cigarette smoking and alcohol consumption (Italy, 1992–1997)
Cases : controls Tertiles of vitamin D intakeb
3 (high) 2 1 (low)
Esophageal cancer
Cigarette smoking
Never smokers + former smokers ‡10 years 80 : 434 1.0 (ref) 1.1 (0.5–2.4) 2.5 (1.2–4.9)
Former smokers <10 years + current smokers <20 cigarettes/day 121 : 216 4.3 (2.1–9.1) 3.2 (1.5–6.8) 5.1 (2.5–10.3)
Current smokers ‡20 cigarettes/day 103 : 93 3.9 (1.6–9.6) 7.5 (3.3–17.2) 8.7 (4.1–18.7)
Alcohol consumption
£2 drinks/day 28 : 298 1.0 (ref) 1.1 (0.4–3.0) 1.6 (0.6–4.3)
3–6 drinks/day 102 : 295 8.3 (2.6–26.7) 11.2 (3.6–34.9) 16.1 (5.2–50.2)
‡7 drinks/day 174 : 150 28.1 (8.5–92.4) 19.3 (6.0–62.0) 41.9 (13.7–128.6)
Oral and pharyngeal cancers
Cigarette smoking
Never smokers + former smokers ‡10 years 188 : 1261 1.0 (ref) 0.9 (0.6–1.3) 0.9 (0.6–1.4)
Former smokers <10 years + current smokers <20 cigarettes/day 353 : 601 2.7 (1.9–4.0) 3.4 (2.4–4.8) 4.5 (3.1–6.3)
Current smokers ‡20 cigarettes/day 263 : 218 6.7 (4.3–10.4) 6.8 (4.4–10.6) 10.4 (6.9–15.5)
Alcohol consumption
£2 drinks/day 224 : 1331 1.0 (ref) 1.0 (0.7–1.3) 0.9 (0.6–1.3)
3–6 drinks/day 183 : 546 1.6 (1.0–2.4) 1.6 (1.0–2.4) 1.8 (1.2–2.7)
‡7 drinks/day 397 : 221 5.8 (3.6–9.3) 6.9 (4.5–10.7) 8.5 (5.7–12.5)
aAdjusted for age, sex, study center, education, total energy intake, alcohol consumption (in models stratified by cigarette smoking), and cigarette smoking
(in models stratified by alcohol consumption).
bTertiles based on distribution among controls.
OR, odds ratio; CI, confidence interval.
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D, increasing serum 25(OH)D concentrations were
unexpectedly associated with increased risk of SCCE among
men, but not among women [29]. Further, increased serum
25(OH)D levels were also associated with significantly
increased risk among both men and women for esophageal
squamous dysplasia, the precursor lesion for SCCE, in a cross-
sectional analysis [30]. In that population, mean serum
25(OH)D levels were 33.3 nmol/l among men and 40.1 nmol/l
among men who developed SCCE [29], substantially lower
than the mean serum concentration of 83 nmol/l among USA
white males in the NHANES III study [31] and most likely
lower than that of our Italian population. There is no
immediate explanation for the apparent discrepancy between
the results of the Chinese study, the first to examine an
association between vitamin D and esophageal cancer using
serum 25(OH)D, and those of other studies, including the
present one, but further research is needed before speculating
on the possibility of a U-shaped association.
Alcohol consumption and tobacco smoking represent the
predominant risk factors for both SCCE and oral and
pharyngeal cancers in our study population. Compared with
never/former smokers with the highest vitamin D intake (those
presumably at lowest baseline risk for SCCE and oral and
pharyngeal cancers), we observed a 9- to 10-fold increased risk
for esophageal and oral and pharyngeal cancers among heavy
smokers with low vitamin D intake. Similarly, compared with
never or light drinkers with high vitamin D intake, heavy
drinkers with low vitamin D intake had an OR of 41.9 for
esophageal cancer and 8.5 for oral and pharyngeal cancers. To
our knowledge, only one other study, a case–control study of
SCCE in France, has evaluated the interaction between alcohol
consumption and vitamin D intake [32], and they reported
a significant protective effect of dietary vitamin D among heavy
drinkers but not among moderate drinkers. In our study, the
favorable effect was observed across strata of tobacco and
alcohol intakes.
Our study was sufficiently large to obtain reasonably precise
risk estimates for vitamin D intake. Cases and controls came
from comparable catchment areas, participation was virtually
complete, and both cases and controls were interviewed in the
hospital setting, thereby reducing potential selection and recall
bias [33]. However, it is well established that vitamin D is
essential to bone health, and low vitamin D levels are associated
with osteoporosis and osteomalacia, as well as muscle strength
and falls [34–36]. Since >50% of controls in our studies were
admitted to hospital for traumas or other orthopedic disorders,
we cannot rule out the possibility that low vitamin D intake
among those controls may have biased our esophageal or oral
and pharyngeal cancer ORs away from the null. However, the
inverse association was not materially different when
comparison was made separately using different categories of
hospital controls.
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